H.B. 175 Opioid Abuse Prevention and Treatment Amendments
| Bill Sponsor:  Rep. Eliason, Steve | Floor Sponsor:  Sen. Shiozawa, Brian E. |
- CoSponsor(s):
Chavez-Houck, R. Daw, B. Hall, C. Hollins, S. Kennedy, M. Noel, M.
- Drafting Attorney: Amy L. West
- Fiscal Analyst: Russell T. Frandsen
- Bill Text
- Introduced
- Enrolled (Currently Displayed)
- Introduced
- Other Versions
- Related Documents
- Information
- Last Action: 21 Mar 2017, Governor Signed
- Last Location: Lieutenant Governor's office for filing
- Effective Date: 9 May 2017
- Session Law Chapter: 180
- Similar Bills
- Sections Affected
Enrolled
Printer FriendlyH.B. 175
1 OPIOID ABUSE PREVENTION AND TREATMENT
2AMENDMENTS
32017 GENERAL SESSION
4STATE OF UTAH
5Chief Sponsor: Steve Eliason
6Senate Sponsor: Brian E. Shiozawa
7 Cosponsors:
8 Rebecca Chavez-Houck
9 Brad M. Daw
Craig Hall
Sandra Hollins
Michael S. Kennedy
Michael E. Noel
10
11 LONG TITLE
12 General Description:
13 This bill requires controlled substance prescribers to receive training in a nationally
14 recognized opioid abuse screening method and requires reimbursement for the
15 screening services.
16 Highlighted Provisions:
17 This bill:
18 ▸ requires controlled substance prescribers to receive training in a nationally
19 recognized opioid abuse screening method;
20 ▸ permits controlled substance prescribers to fulfill continuing education requirements
21 through training in the screening method;
22 ▸ permits controlled substance prescribers who receive a DATA 2000 waiver to use
23 the waiver to fulfill certain continuing education requirements;
24 ▸ requires Medicaid reimbursement to health care providers for screening services;
25 ▸ requires the Public Employees' Benefit and Insurance Program to reimburse health
26 care providers for screening services; and
27 ▸ makes technical changes.
28 Money Appropriated in this Bill:
29 None
30 Other Special Clauses:
31 None
32 Utah Code Sections Affected:
33 AMENDS:
34 58-37-6.5, as repealed and reenacted by Laws of Utah 2013, Chapter 450
35 ENACTS:
36 26-18-21, Utah Code Annotated 1953
37 49-20-414, Utah Code Annotated 1953
38
39 Be it enacted by the Legislature of the state of Utah:
40 Section 1. Section 26-18-21 is enacted to read:
41 26-18-21. Screening, Brief Intervention, and Referral to Treatment Medicaid
42 reimbursement.
43 (1) As used in this section:
44 (a) "Controlled substance prescriber" means a controlled substance prescriber, as that
45 term is defined in Section 58-37-6.5, who:
46 (i) has a record of having completed SBIRT training, in accordance with Subsection
47 58-37-6.5(2), before providing the SBIRT services; and
48 (ii) is a Medicaid enrolled health care provider.
49 (b) "SBIRT" means the same as that term is defined in Section 58-37-6.5.
50 (2) The department shall reimburse a controlled substance prescriber who provides
51 SBIRT services to a Medicaid enrollee who is 13 years of age or older for the SBIRT services.
52 Section 2. Section 49-20-414 is enacted to read:
53 49-20-414. Screening, Brief Intervention, and Referral to Treatment program
54 reimbursement.
55 (1) As used in this section:
56 (a) "Controlled substance prescriber" means a controlled substance prescriber, as that
57 term is defined in Section 58-37-6.5, who:
58 (i) has a record of having completed SBIRT training, in accordance with Subsection
59 58-37-6.5(2), before providing the SBIRT services; and
60 (ii) is a program enrolled controlled substance prescriber.
61 (b) "SBIRT" means the same as that term is defined in Section 58-37-6.5.
62 (2) The health program offered to the state employee risk pool under Section
63 49-20-202 shall reimburse a controlled substance prescriber who provides SBIRT services to a
64 covered individual who is 13 years of age or older for the SBIRT services.
65 Section 3. Section 58-37-6.5 is amended to read:
66 58-37-6.5. Continuing education for controlled substance prescribers.
67 (1) For the purposes of this section:
68 (a) "Controlled substance prescriber" means an individual, other than a veterinarian,
69 who:
70 (i) is licensed to prescribe a controlled substance under Title 58, Chapter 37, Utah
71 Controlled Substances Act; and
72 (ii) possesses the authority, in accordance with the individual's scope of practice, to
73 prescribe schedule II controlled substances and schedule III controlled substances that are
74 applicable to opioid narcotics, hypnotic depressants, or psychostimulants.
75 (b) "D.O." means an osteopathic physician and surgeon licensed under Title 58,
76 Chapter 68, Utah Osteopathic Medical Practice Act.
77 [(b)] (c) "FDA" means the United States Food and Drug Administration.
78 [(c)] (d) "M.D." means a physician and surgeon licensed under Title 58, Chapter 67,
79 Utah Medical Practice Act.
80 [(d) "D.O." means an osteopathic physician and surgeon licensed under Title 58,
81Chapter 68, Utah Osteopathic Medical Practice Act.]
82 (e) "SBIRT" means the Screening, Brief Intervention, and Referral to Treatment
83 approach used by the federal Substance Abuse and Mental Health Services Administration or
84 defined by the division, in consultation with the Division of Substance Abuse and Mental
85 Health, by administrative rule, in accordance with Title 63G, Chapter 3, Utah Administrative
86 Rulemaking Act.
87 (2) (a) Beginning with the licensing period that begins after January 1, 2014, as a
88 condition precedent for license renewal, each controlled substance prescriber shall complete at
89 least four continuing education hours per licensing period that satisfy the requirements of
90 Subsections (3) and (4).
91 (b) (i) Beginning with the licensing period that begins after January 1, 2024, as a
92 condition precedent for license renewal, each controlled substance prescriber shall complete at
93 least 3.5 continuing education hours in an SBIRT-training class that satisfies the requirements
94 of Subsection (5).
95 (ii) Completion of the SBIRT-training class, in compliance with Subsection (2)(b)(i),
96 fulfills the continuing education hours requirement in Subsection (4) for the licensing period in
97 which the class was completed.
98 (iii) A controlled substance prescriber:
99 (A) need only take the SBIRT-training class once during the controlled substance
100 prescriber's licensure in the state; and
101 (B) shall provide a completion record of the SBIRT-training class in order to be
102 reimbursed for SBIRT services to patients, in accordance with Section 26-18-21 and Section
103 49-20-414.
104 (3) As provided in Subsection 58-37f-402(8), the online tutorial and passing the online
105 test described in Section 58-37f-402 shall count as 1/2 hour of continuing professional
106 education under Subsection (2) per licensing period.
107 (4) A controlled substance prescriber shall complete at least 3.5 hours of continuing
108 education [hours] in one or more controlled substance prescribing classes, except dentists who
109 shall complete at least [2 such] two hours, that satisfy the requirements of Subsections (5) and
110 (7).
111 (5) A controlled substance prescribing class shall:
112 (a) satisfy the division's requirements for the continuing education required for the
113 renewal of the controlled substance prescriber's respective license type;
114 (b) be delivered by an accredited or approved continuing education provider
115 recognized by the division as offering continuing education appropriate for the controlled
116 substance prescriber's respective license type; and
117 (c) include a postcourse knowledge assessment.
118 (6) An M.D. or D.O. completing continuing professional education hours under
119 Subsection (4) shall complete those hours in classes that qualify for the American Medical
120 Association Physician's Recognition Award Category 1 Credit.
121 (7) The 3.5 hours of the controlled substance prescribing classes under Subsection (4)
122 shall include educational content covering the following:
123 (a) the scope of the controlled substance abuse problem in Utah and the nation;
124 (b) all elements of the FDA Blueprint for Prescriber Education under the FDA's
125 Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation
126 Strategy, as published July 9, 2012, or as it may be subsequently revised;
127 (c) the national and Utah-specific resources available to prescribers to assist in
128 appropriate controlled substance and opioid prescribing;
129 (d) patient record documentation for controlled substance and opioid prescribing; and
130 (e) office policies, procedures, and implementation.
131 (8) (a) The division, in consultation with the Utah Medical Association Foundation,
132 shall determine whether a particular controlled substance prescribing class satisfies the
133 educational content requirements of Subsections (5) and (7) for an M.D. or D.O.
134 (b) The division, in consultation with the applicable professional licensing boards,
135 shall determine whether a particular controlled substance prescribing class satisfies the
136 educational content requirements of Subsections (5) and (7) for a controlled substance
137 prescriber other than an M.D. or D.O.
138 (c) The division may by rule establish a committee that may audit compliance with the
139 Utah Risk Evaluation and Mitigation Strategy (REMS) Educational Programming Project
140 grant, that satisfies the educational content requirements of Subsections (5) and (7) for a
141 controlled substance prescriber.
142 (9) A controlled substance prescribing class required under this section:
143 (a) may be held:
144 (i) in conjunction with other continuing professional education programs; and
145 (ii) online; and
146 (b) does not increase the total number of state-required continuing professional
147 education hours required for prescriber licensing.
148 (10) The division may establish rules, in accordance with Title 63G, Chapter 3, Utah
149 Administrative Rulemaking Act, to implement this section.
150 (11) A controlled substance prescriber who, on or after July 1, 2017, obtains a waiver
151 to treat opioid dependency with narcotic medications, in accordance with the Drug Addiction
152 Treatment Act of 2000, 21 U.S.C. Sec. 823 et seq., may use the waiver to satisfy the 3.5 hours
153 of the continuing education requirement under Subsection (4) for two consecutive licensing
154 periods.
2
3
4
5
6
7 Cosponsors:
8 Rebecca Chavez-Houck
9 Brad M. Daw
Craig Hall
Sandra Hollins
Michael S. Kennedy
Michael E. Noel
10
11 LONG TITLE
12 General Description:
13 This bill requires controlled substance prescribers to receive training in a nationally
14 recognized opioid abuse screening method and requires reimbursement for the
15 screening services.
16 Highlighted Provisions:
17 This bill:
18 ▸ requires controlled substance prescribers to receive training in a nationally
19 recognized opioid abuse screening method;
20 ▸ permits controlled substance prescribers to fulfill continuing education requirements
21 through training in the screening method;
22 ▸ permits controlled substance prescribers who receive a DATA 2000 waiver to use
23 the waiver to fulfill certain continuing education requirements;
24 ▸ requires Medicaid reimbursement to health care providers for screening services;
25 ▸ requires the Public Employees' Benefit and Insurance Program to reimburse health
26 care providers for screening services; and
27 ▸ makes technical changes.
28 Money Appropriated in this Bill:
29 None
30 Other Special Clauses:
31 None
32 Utah Code Sections Affected:
33 AMENDS:
34 58-37-6.5, as repealed and reenacted by Laws of Utah 2013, Chapter 450
35 ENACTS:
36 26-18-21, Utah Code Annotated 1953
37 49-20-414, Utah Code Annotated 1953
38
39 Be it enacted by the Legislature of the state of Utah:
40 Section 1. Section 26-18-21 is enacted to read:
41 26-18-21. Screening, Brief Intervention, and Referral to Treatment Medicaid
42 reimbursement.
43 (1) As used in this section:
44 (a) "Controlled substance prescriber" means a controlled substance prescriber, as that
45 term is defined in Section 58-37-6.5, who:
46 (i) has a record of having completed SBIRT training, in accordance with Subsection
47 58-37-6.5(2), before providing the SBIRT services; and
48 (ii) is a Medicaid enrolled health care provider.
49 (b) "SBIRT" means the same as that term is defined in Section 58-37-6.5.
50 (2) The department shall reimburse a controlled substance prescriber who provides
51 SBIRT services to a Medicaid enrollee who is 13 years of age or older for the SBIRT services.
52 Section 2. Section 49-20-414 is enacted to read:
53 49-20-414. Screening, Brief Intervention, and Referral to Treatment program
54 reimbursement.
55 (1) As used in this section:
56 (a) "Controlled substance prescriber" means a controlled substance prescriber, as that
57 term is defined in Section 58-37-6.5, who:
58 (i) has a record of having completed SBIRT training, in accordance with Subsection
59 58-37-6.5(2), before providing the SBIRT services; and
60 (ii) is a program enrolled controlled substance prescriber.
61 (b) "SBIRT" means the same as that term is defined in Section 58-37-6.5.
62 (2) The health program offered to the state employee risk pool under Section
63 49-20-202 shall reimburse a controlled substance prescriber who provides SBIRT services to a
64 covered individual who is 13 years of age or older for the SBIRT services.
65 Section 3. Section 58-37-6.5 is amended to read:
66 58-37-6.5. Continuing education for controlled substance prescribers.
67 (1) For the purposes of this section:
68 (a) "Controlled substance prescriber" means an individual, other than a veterinarian,
69 who:
70 (i) is licensed to prescribe a controlled substance under Title 58, Chapter 37, Utah
71 Controlled Substances Act; and
72 (ii) possesses the authority, in accordance with the individual's scope of practice, to
73 prescribe schedule II controlled substances and schedule III controlled substances that are
74 applicable to opioid narcotics, hypnotic depressants, or psychostimulants.
75 (b) "D.O." means an osteopathic physician and surgeon licensed under Title 58,
76 Chapter 68, Utah Osteopathic Medical Practice Act.
77 [
78 [
79 Utah Medical Practice Act.
80 [
81
82 (e) "SBIRT" means the Screening, Brief Intervention, and Referral to Treatment
83 approach used by the federal Substance Abuse and Mental Health Services Administration or
84 defined by the division, in consultation with the Division of Substance Abuse and Mental
85 Health, by administrative rule, in accordance with Title 63G, Chapter 3, Utah Administrative
86 Rulemaking Act.
87 (2) (a) Beginning with the licensing period that begins after January 1, 2014, as a
88 condition precedent for license renewal, each controlled substance prescriber shall complete at
89 least four continuing education hours per licensing period that satisfy the requirements of
90 Subsections (3) and (4).
91 (b) (i) Beginning with the licensing period that begins after January 1, 2024, as a
92 condition precedent for license renewal, each controlled substance prescriber shall complete at
93 least 3.5 continuing education hours in an SBIRT-training class that satisfies the requirements
94 of Subsection (5).
95 (ii) Completion of the SBIRT-training class, in compliance with Subsection (2)(b)(i),
96 fulfills the continuing education hours requirement in Subsection (4) for the licensing period in
97 which the class was completed.
98 (iii) A controlled substance prescriber:
99 (A) need only take the SBIRT-training class once during the controlled substance
100 prescriber's licensure in the state; and
101 (B) shall provide a completion record of the SBIRT-training class in order to be
102 reimbursed for SBIRT services to patients, in accordance with Section 26-18-21 and Section
103 49-20-414.
104 (3) As provided in Subsection 58-37f-402(8), the online tutorial and passing the online
105 test described in Section 58-37f-402 shall count as 1/2 hour of continuing professional
106 education under Subsection (2) per licensing period.
107 (4) A controlled substance prescriber shall complete at least 3.5 hours of continuing
108 education [
109 shall complete at least [
110 (7).
111 (5) A controlled substance prescribing class shall:
112 (a) satisfy the division's requirements for the continuing education required for the
113 renewal of the controlled substance prescriber's respective license type;
114 (b) be delivered by an accredited or approved continuing education provider
115 recognized by the division as offering continuing education appropriate for the controlled
116 substance prescriber's respective license type; and
117 (c) include a postcourse knowledge assessment.
118 (6) An M.D. or D.O. completing continuing professional education hours under
119 Subsection (4) shall complete those hours in classes that qualify for the American Medical
120 Association Physician's Recognition Award Category 1 Credit.
121 (7) The 3.5 hours of the controlled substance prescribing classes under Subsection (4)
122 shall include educational content covering the following:
123 (a) the scope of the controlled substance abuse problem in Utah and the nation;
124 (b) all elements of the FDA Blueprint for Prescriber Education under the FDA's
125 Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation
126 Strategy, as published July 9, 2012, or as it may be subsequently revised;
127 (c) the national and Utah-specific resources available to prescribers to assist in
128 appropriate controlled substance and opioid prescribing;
129 (d) patient record documentation for controlled substance and opioid prescribing; and
130 (e) office policies, procedures, and implementation.
131 (8) (a) The division, in consultation with the Utah Medical Association Foundation,
132 shall determine whether a particular controlled substance prescribing class satisfies the
133 educational content requirements of Subsections (5) and (7) for an M.D. or D.O.
134 (b) The division, in consultation with the applicable professional licensing boards,
135 shall determine whether a particular controlled substance prescribing class satisfies the
136 educational content requirements of Subsections (5) and (7) for a controlled substance
137 prescriber other than an M.D. or D.O.
138 (c) The division may by rule establish a committee that may audit compliance with the
139 Utah Risk Evaluation and Mitigation Strategy (REMS) Educational Programming Project
140 grant, that satisfies the educational content requirements of Subsections (5) and (7) for a
141 controlled substance prescriber.
142 (9) A controlled substance prescribing class required under this section:
143 (a) may be held:
144 (i) in conjunction with other continuing professional education programs; and
145 (ii) online; and
146 (b) does not increase the total number of state-required continuing professional
147 education hours required for prescriber licensing.
148 (10) The division may establish rules, in accordance with Title 63G, Chapter 3, Utah
149 Administrative Rulemaking Act, to implement this section.
150 (11) A controlled substance prescriber who, on or after July 1, 2017, obtains a waiver
151 to treat opioid dependency with narcotic medications, in accordance with the Drug Addiction
152 Treatment Act of 2000, 21 U.S.C. Sec. 823 et seq., may use the waiver to satisfy the 3.5 hours
153 of the continuing education requirement under Subsection (4) for two consecutive licensing
154 periods.
Bill Status / Votes
• Senate Actions • House Actions • Fiscal Actions • Other Actions
| Date | Action | Location | Vote |
| 1/23/2017 | Bill Numbered but not Distributed | Legislative Research and General Counsel | |
| 1/23/2017 | Numbered Bill Publicly Distributed | Legislative Research and General Counsel | |
| 1/23/2017 | LFA/ bill sent to agencies for fiscal input | Legislative Research and General Counsel | |
| 1/24/2017 | House/ received bill from Legislative Research | Clerk of the House | |
| 1/24/2017 | House/ 1st reading (Introduced) | House Rules Committee | |
| 1/26/2017 | LFA/ fiscal note sent to sponsor | House Rules Committee | |
| 1/30/2017 | LFA/ fiscal note publicly available | House Rules Committee | |
| 1/31/2017 | House/ received fiscal note from Fiscal Analyst | House Rules Committee | |
| 2/1/2017 | House/ to standing committee | House Health and Human Services Committee | |
| 2/2/2017 | House Comm - Favorable Recommendation | House Health and Human Services Committee | 12 0 0 |
| 2/6/2017 (12:14:34 PM) | House/ committee report favorable | House Health and Human Services Committee | |
| 2/6/2017 (12:14:35 PM) | House/ 2nd reading | House 3rd Reading Calendar for House bills | |
| 2/17/2017 (11:36:53 AM) | House/ 3rd reading | House 3rd Reading Calendar for House bills | |
| 2/17/2017 (11:43:11 AM) | House/ passed 3rd reading | Senate Secretary | 72 0 3 |
| 2/17/2017 (11:43:13 AM) | House/ to Senate | Senate Secretary | |
| 2/17/2017 | Senate/ received from House | Waiting for Introduction in the Senate | |
| 2/17/2017 | Senate/ 1st reading (Introduced) | Senate Rules Committee | |
| 2/21/2017 | Senate/ to standing committee | Senate Health and Human Services Committee | |
| 2/22/2017 | Senate Comm - Favorable Recommendation | Senate Health and Human Services Committee | 5 0 3 |
| 2/23/2017 (2:41:32 PM) | Senate/ committee report favorable | Senate Health and Human Services Committee | |
| 2/23/2017 (2:41:33 PM) | Senate/ placed on 2nd Reading Calendar | Senate 2nd Reading Calendar | |
| 3/2/2017 (2:44:29 PM) | Senate/ 2nd reading | Senate 2nd Reading Calendar | |
| 3/2/2017 (2:49:55 PM) | Senate/ passed 2nd reading | Senate 3rd Reading Calendar | 25 0 4 |
| 3/2/2017 (2:50:07 PM) | Senate/ 3rd reading | Senate 3rd Reading Calendar | |
| 3/2/2017 (2:50:20 PM) | Senate/ placed on 3rd Reading Calendar table | Senate 3rd Reading Calendar Table | |
| 3/5/2017 | Senate/ lifted from table | Senate 3rd Reading Calendar Table | |
| 3/6/2017 | Senate/ placed back on 3rd Reading Calendar | Senate 3rd Reading Calendar | |
| 3/7/2017 (6:18:12 PM) | Senate/ passed 3rd reading | Senate President | 27 0 2 |
| 3/7/2017 (6:18:13 PM) | Senate/ signed by President/ returned to House | House Speaker | |
| 3/7/2017 (6:18:14 PM) | Senate/ to House | House Speaker | |
| 3/8/2017 | House/ received from Senate | House Speaker | |
| 3/8/2017 | House/ signed by Speaker/ sent for enrolling | Legislative Research and General Counsel / Enrolling | |
| 3/9/2017 | Bill Received from House for Enrolling | Legislative Research and General Counsel / Enrolling | |
| 3/9/2017 | Draft of Enrolled Bill Prepared | Legislative Research and General Counsel / Enrolling | |
| 3/17/2017 | Enrolled Bill Returned to House or Senate | Clerk of the House | |
| 3/17/2017 | House/ enrolled bill to Printing | Clerk of the House | |
| 3/17/2017 | House/ to Governor | Executive Branch - Governor | |
| 3/21/2017 | Governor Signed | Lieutenant Governor's office for filing |
Committee Hearings/Floor Debate
- Committee Hearings